Non-destructive detection of matrix stabilization correlates with enhanced mechanical properties of self-assembled articular cartilage.


Journal

Journal of tissue engineering and regenerative medicine
ISSN: 1932-7005
Titre abrégé: J Tissue Eng Regen Med
Pays: England
ID NLM: 101308490

Informations de publication

Date de publication:
04 2019
Historique:
received: 08 03 2018
revised: 05 12 2018
accepted: 13 02 2019
pubmed: 17 2 2019
medline: 17 4 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

Tissue engineers rely on expensive, time-consuming, and destructive techniques to monitor the composition, microstructure, and function of engineered tissue equivalents. A non-destructive solution to monitor tissue quality and maturation would greatly reduce costs and accelerate the development of tissue-engineered products. The objectives of this study were to (a) determine whether matrix stabilization with exogenous lysyl oxidase-like protein-2 (LOXL2) with recombinant hyaluronan and proteoglycan link protein-1 (LINK) would result in increased compressive and tensile properties in self-assembled articular cartilage constructs, (b) evaluate whether label-free, non-destructive fluorescence lifetime imaging (FLIm) could be used to infer changes in both biochemical composition and biomechanical properties, (c) form quantitative relationships between destructive and non-destructive measurements to determine whether the strength of these correlations is sufficient to replace destructive testing methods, and (d) determine whether support vector machine (SVM) learning can predict LOXL2-induced collagen crosslinking. The combination of exogenous LOXL2 and LINK proteins created a synergistic 4.9-fold increase in collagen crosslinking density and an 8.3-fold increase in tensile strength as compared with control (CTL). Compressive relaxation modulus was increased 5.9-fold with addition of LOXL2 and 3.4-fold with combined treatments over CTL. FLIm parameters had strong and significant correlations with tensile properties (R

Identifiants

pubmed: 30770656
doi: 10.1002/term.2824
pmc: PMC6461514
mid: NIHMS1013059
doi:

Substances chimiques

Cross-Linking Reagents 0
Extracellular Matrix Proteins 0
Proteoglycans 0
link protein 0
Collagen 9007-34-5
Amino Acid Oxidoreductases EC 1.4.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

637-648

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR067821
Pays : United States
Organisme : NIH HHS
ID : R01AR067821
Pays : United States
Organisme : California Institute for Regenerative Medicine
ID : RT3-07981
Pays : International

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Références

Tissue Eng Part C Methods. 2011 Apr;17(4):495-504
pubmed: 21303258
J Biomech. 2003 Dec;36(12):1785-96
pubmed: 14614932
IEEE Trans Neural Netw. 2002;13(2):415-25
pubmed: 18244442
IEEE Trans Med Imaging. 2016 Aug;35(8):1802-11
pubmed: 26890641
FASEB J. 2013 Jun;27(6):2421-30
pubmed: 23457219
Biochem J. 1979 Jan 1;177(1):237-47
pubmed: 34388
PLoS One. 2008 Jul 30;3(7):e2795
pubmed: 18665220
J Appl Physiol (1985). 2007 Dec;103(6):2068-76
pubmed: 17901242
J Biomech. 2006;39(2):312-22
pubmed: 16321633
Rev Sci Instrum. 2009 Jun;80(6):065104
pubmed: 19566223
Biomed Opt Express. 2018 Aug 06;9(9):4064-4076
pubmed: 30615748
J Biol Chem. 2013 Sep 27;288(39):28243-53
pubmed: 23940040
Nat Rev Rheumatol. 2015 Jan;11(1):21-34
pubmed: 25247412
J Biol Chem. 2005 Feb 18;280(7):5435-48
pubmed: 15590670
Phys Med Biol. 2012 Feb 21;57(4):843-65
pubmed: 22290334
Science. 2012 Nov 16;338(6109):917-21
pubmed: 23161992
Agents Actions Suppl. 1993;39:27-48
pubmed: 8456641
Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29
pubmed: 26153368
BMC Med Inform Decis Mak. 2010 Mar 22;10:16
pubmed: 20307319
Biophys J. 2012 Dec 5;103(11):2379-88
pubmed: 23283237
Atherosclerosis. 2011 Mar;215(1):96-102
pubmed: 21193196
J Biol Chem. 2003 Jun 6;278(23):21083-91
pubmed: 12663660
Rev Sci Instrum. 2014 Mar;85(3):034303
pubmed: 24689603
Crit Rev Biomed Eng. 2007;35(5):363-411
pubmed: 19392643
Tissue Eng Part C Methods. 2010 Dec;16(6):1471-9
pubmed: 20486781
Crit Rev Biomed Eng. 2009;37(1-2):1-57
pubmed: 20201770
J Orthop Res. 2017 Nov;35(11):2452-2464
pubmed: 28294398
Eur Cell Mater. 2018 Jul 27;36:30-43
pubmed: 30051455
J Orthop Res. 1996 Mar;14(2):334-9
pubmed: 8648515
Biomaterials. 2012 Apr;33(11):3187-94
pubmed: 22284584
J Biomech. 1991;24(11):1007-18
pubmed: 1761579
Stem Cells. 2009 May;27(5):1164-72
pubmed: 19418448
J Biol Chem. 1988 Jun 5;263(16):7560-6
pubmed: 3372500
J Biomed Biotechnol. 2011;2011:432830
pubmed: 21876642
Photochem Photobiol. 1998 Nov;68(5):603-32
pubmed: 9825692
Matrix Biol. 2013 Jan;32(1):32-8
pubmed: 23266527
Magn Reson Med. 2012 Jun;67(6):1815-26
pubmed: 22179972
Coll Relat Res. 1984 Oct;4(5):323-37
pubmed: 6509889
Tissue Eng. 2006 Apr;12(4):969-79
pubmed: 16674308
Arch Biochem Biophys. 1961 May;93:440-7
pubmed: 13786180
Beitr Pathol. 1973 Nov;150(2):174-87
pubmed: 4129194
J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):37-44
pubmed: 9448060
Chest. 2001 Jul;120(1):233-9
pubmed: 11451844
Tissue Eng Part C Methods. 2012 Jun;18(6):433-43
pubmed: 22166112
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14360-14365
pubmed: 27911782
J Biomech. 1987;20(7):703-14
pubmed: 3654668
IEEE Trans Med Imaging. 2015 Jan;34(1):156-66
pubmed: 25163056
Cell Res. 2002 Mar;12(1):19-32
pubmed: 11942407
J Biomed Opt. 2018 Dec;23(12):1-8
pubmed: 30578627
PLoS One. 2017 Aug 2;12(8):e0182531
pubmed: 28767737
Histochem J. 1979 Jul;11(4):447-55
pubmed: 91593

Auteurs

Anne K Haudenschild (AK)

Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.

Benjamin E Sherlock (BE)

Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.

Xiangnan Zhou (X)

Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.

Jerry C Hu (JC)

Department of Biomedical Engineering, University of California Irvine, Irvine, CA, USA.

J Kent Leach (JK)

Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.
Department of Orthopaedic Surgery, University of California Davis Medical Center, Sacramento, CA, USA.

Laura Marcu (L)

Department of Biomedical Engineering, University of California Davis, Davis, CA, USA.

Kyriacos A Athanasiou (KA)

Department of Biomedical Engineering, University of California Irvine, Irvine, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH